BWM
EDIT icon

Baystate Wealth Management’s Editas Medicine EDIT Stock Holding History

Baystate Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11
Closed – – 698
2020
Q3 		$0 Buy
+11
New +$358 ﹤0.01% 663

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Baystate Wealth Management's EDIT Position: Q4 2020 in Review

Baystate Wealth Management sold out of Editas Medicine (EDIT) in Q4 2020, closing a stake of 11 shares.

Baystate Wealth Management first reported a position in EDIT in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 311 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

  • Baystate Wealth Management reported no remaining Editas Medicine position as of Q4 2020 after selling out during the quarter.
  • Baystate Wealth Management sold 11 Editas Medicine shares in Q4 2020.
  • Baystate Wealth Management first reported a position in Editas Medicine in Q3 2020 and held it in 1 quarter.
  • Baystate Wealth Management's Editas Medicine position peaked at $0 in Q3 2020.
  • 311 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Baystate Wealth Management's 13F filing for Q4 2020, filed 15 Jan 2021.